October 2025
1. BARDSEN T, Vollsaeter M
   Understanding lung disease following extremely preterm birth.
   Thorax. 2025 Oct 24:thorax-2025-223547. doi: 10.1136/thorax-2025-223547.
   

   >> Share

   
   
2. BOKOBZA I, Le Sayec M, Bossley C, Brugha R, et al
   Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluation.
   Thorax. 2025;80:849-852.
   

   >> Share

   
   September 2025
3. MOORTHY A, Kaur A, Parekh AH, Panigrahi MK, et al
   Congenital bronchial atresia.
   Thorax. 2025 Sep 17:thorax-2025-223763. doi: 10.1136/thorax-2025-223763.
   

   >> Share

   
   August 2025
4. MAHER RE, Cytlak-Chaudhuri UM, Aleem S, Barry P, et al
   Effect of elexacaftor/tezacaftor/ivacaftor on systemic inflammation in cystic fibrosis.
   Thorax. 2025;80:604-615.
   

   >> Share

   
   
5. ALARCON-MARTINEZ T, Mainzer RM, Ranganathan S, Doyle LW, et al
   Spirometry phenotypes at 8 years in children born extremely preterm or with extremely low birth weight.
   Thorax. 2025 Aug 11:thorax-2024-222602. doi: 10.1136/thorax-2024-222602.
   

   >> Share

   
   June 2025
6. SHANTHIKUMAR S, Gubbels L, Wong ATC, Walker H, et al
   Inflammation in preschool cystic fibrosis is of mixed phenotype, extends beyond the lung and is differentially modified by CFTR modulators.
   Thorax. 2025;80:433-444.
   

   >> Share

   
   April 2025
7. YNGVADOTTIR B, Richman L, Andreou A, Woodley J, et al
   Inherited predisposition to pneumothorax: estimating the frequency of Birt-Hogg-Dube syndrome from genomics and population cohorts.
   Thorax. 2025 Apr 10:thorax-2024-221738. doi: 10.1136/thorax-2024-221738.
   

   >> Share

   
   September 2024
8. ROBINSON PD
   Ageing and ivacaftor: unravelling the long-term effects.
   Thorax. 2024;79:901-902.
   

   >> Share

   
   
9. MERLO CA, Thorat T, DerSarkissian M, McGarry LJ, et al
   Long-term impact of ivacaftor on mortality rate and health outcomes in people with cystic fibrosis.
   Thorax. 2024;79:925-933.
   

   >> Share

   
   
10. MERLO CA, McGarry LJ, Thorat T, Nguyen C, et al
    Impact of age at ivacaftor initiation on pulmonary outcomes among people with cystic fibrosis.
    Thorax. 2024;79:915-924.
    

    >> Share

    
    August 2024
11. CUYX S, Ramalho AS, Fieuws S, Corthout N, et al
    Rectal organoid morphology analysis (ROMA) as a novel physiological assay for diagnostic classification in cystic fibrosis.
    Thorax. 2024;79:834-841.
    

    >> Share

    
    
12. GRIESE M, Kurland G, Cidon M, Deterding RR, et al
    Pulmonary fibrosis may begin in infancy: from childhood to adult interstitial lung disease.
    Thorax. 2024 Aug 17:thorax-2024-221772. doi: 10.1136/thorax-2024-221772.
    

    >> Share

    
    July 2024
13. ASHARAM K, Mitku AAA, Ramsay L, Jeena PM, et al
    Environmental exposures associated with early childhood recurrent wheezing in the mother and child in the environment birth cohort: a time-to-event study.
    Thorax. 2024 Jul 4:thorax-2023-221150. doi: 10.1136/thorax-2023-221150.
    

    >> Share

    
    April 2024
14. GRUDZINSKA FS, Scott A
    Unravelling the neutrophil enigma: a new insight into RSV-induced bronchiolitis in infants.
    Thorax. 2024 Apr 4:thorax-2023-221130. doi: 10.1136/thorax-2023-221130.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share